Le Lézard
Classified in: Health
Subjects: PER, MAT, SHM

Trulieve Reports Results of 2022 Annual Meeting of Shareholders


TALLAHASSEE, Fla., June 10, 2022 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the results of its Annual Meeting of Shareholders held on June 8, 2022.

The Company put forward the following resolutions to be voted on by shareholders at the meeting, all of which were approved: (i) to elect eight directors for the forthcoming year from the nominees proposed by the Board; and (ii) to appoint Marcum LLP as auditors for the Company and authorization of the Board of Directors to fix the auditors' remuneration and terms of engagement.

A total of 97,288,636 of the 184,184,142 votes attached to all outstanding shares of the Company on an as-converted basis as at the record date voted at the meeting, representing 52.8% of outstanding shares on an as-converted basis.

Election of Directors: 
Each of the directors elected at the Meeting, being Kim Rivers, Giannella Alvarez, Thad Beshears, Peter Healy, Richard May, Thomas Millner, Jane Morreau and Susan Thronson, will hold office until the next annual general meeting of the Company or until their earlier resignation or removal.

Appointment of Auditors:
Marcum LLP were re-appointed as Auditors of the Corporation for the 2022 fiscal year with the Directors authorized to fix their remuneration.  

About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com.

Facebook: @Trulieve
Instagram: @Trulieve_ 
Twitter: @Trulieve 

Investor Contact
Christine Hersey, Executive Director of Investor Relations
+1 (424) 202-0210
[email protected]

Media Contact
Rob Kremer, Executive Director of Corporate Communications
+1 (404) 218-3077
[email protected]

SOURCE Trulieve Cannabis Corp.


These press releases may also interest you

at 09:34
The below resolutions were passed at Medicover's annual general meeting (the "AGM") held today on 26 April 2024. Election of the board of directors and auditor The AGM resolved, in accordance with the proposal from the nomination committee, that the...

at 09:00
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
Tolland Hill Family Dental is thrilled to announce the addition of Dr. Conway Ma to its esteemed team of dental professionals. Tolland Hill Family Dental offers a wide range of services, catering to patients of all ages. From a child's first dental...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...

at 09:00
Arbele, a clinical-stage biotechnology company focused...



News published on and distributed by: